The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bahcall Safi R since year 2005.
The trader's CIK number is 1325719.
At the time of this reporting, Bahcall Safi R is the President and CEO of Synta Pharmaceuticals Corp .
(stock ticker symbol SNTA).
See this page for all insider trading activities at Synta Pharmaceuticals Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-11-13||SNTA||Synta Pharmaceuticals Corp||Buy||20,000||3.75||75,000|
|2013-06-28||SNTA||Synta Pharmaceuticals Corp||Buy||10,000||5.03||50,300|
|2013-06-21||SNTA||Synta Pharmaceuticals Corp||Buy||20,000||4.12||82,380|
|2013-06-14||SNTA||Synta Pharmaceuticals Corp||Buy||10,000||4.06||40,550|
|2013-06-06||SNTA||Synta Pharmaceuticals Corp||Buy||10,000||4.04||40,390|
|2012-11-12||SNTA||Synta Pharmaceuticals Corp||Buy||10,000||7.12||71,200|
|2012-06-29||SNTA||Synta Pharmaceuticals Corp||Buy||10,000||5.34||53,370|
|2011-03-15||SNTA||Synta Pharmaceuticals Corp||Buy||5,000||4.45||22,250|
|2010-06-10||SNTA||Synta Pharmaceuticals Corp||Buy||10,000||3.05||30,530|
|2010-01-08||SNTA||Synta Pharmaceuticals Corp||Buy||22,222||4.50||99,999|
|2009-08-06||SNTA||Synta Pharmaceuticals Corp||Buy||20,000||2.84||56,720|
|2007-11-26||SNTA||Synta Pharmaceuticals Corp||Buy||5,000||7.83||39,140|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bahcall Safi R (President and CEO of Synta Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.